(Q24307887)

GOA release 2020-03-11

Dipeptidyl peptidase 4

1 reference

peptidyl-dipeptidase inhibitor activity

GOA release 2020-03-11

1 reference

Simpson-Golabi-Behmel syndrome

GOA release 2020-03-11

1 reference

Jamshid Davoodi

1

0 references

John Kelly

series ordinal

2

0 references

Nathalie H Gendron

series ordinal

3

0 references

Alex E MacKenzie

series ordinal

4

0 references

language of work or name

English

0 references

publication date

June 2007

0 references

published in

Proteomics

0 references

volume

7

0 references

issue

13

0 references

page(s)

2300-10

0 references

cites work

The role of glypicans in mammalian development

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

Structure and function of heparan sulphate proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

Heparan sulphate proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

Evidence for a role of dipeptidyl peptidase IV in fibronectin-mediated interactions of hepatocytes with extracellular matrix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) specifically suppress proliferation and modulate cytokine production of strongly CD26 expressing U937 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

Simpson-Golabi-Behmel syndrome: genotype/phenotype analysis of 18 affected males from 7 unrelated families

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

Syndecans, signaling, and cell adhesion

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

Glypican-3 modulates BMP- and FGF-mediated effects during renal branching morphogenesis

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

glypican-3 controls cellular responses to Bmp4 in limb patterning and skeletal development

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

Overgrowth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signaling

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

Genomic organization and primary characterization of miap-3: the murine homologue of human X-linked IAP.

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

A clinical and molecular study of a patient with Simpson-Golabi-Behmel syndrome

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

Dipeptidyl peptidase IV (DPP-IV) from pig kidney cleaves analogs of bovine growth hormone-releasing factor (bGRF) modified at position 2 with Ser, Thr or Val. Extended DPP-IV substrate specificity?

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

Glypican-3 modulates inhibitory Bmp2-Smad signaling to control renal development in vivo

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

Dipeptidyl peptidase IV (DP IV, CD26) is involved in regulation of DNA synthesis in human keratinocytes

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

CD26 mediates the action of HIV-1 Tat protein on DNA synthesis and cytokine production in U937 cells

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

The emerging roles of cell surface heparan sulfate proteoglycans

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

Syndecan proteoglycans and cell adhesion

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

Syndecans: synergistic activators of cell adhesion

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor-beta 1 in PWM-stimulated PBMC and T cells

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26.

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat's immunosuppressive activity.

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

OCI-5/rat glypican-3 binds to fibroblast growth factor-2 but not to insulin-like growth factor-2.

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

The N-terminal structure of HIV-1 Tat is required for suppression of CD26-dependent T cell growth

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

Down-regulation of T cell activation following inhibition of dipeptidyl peptidase IV/CD26 by the N-terminal part of the thromboxane A2 receptor

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner.

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

Processing by proprotein convertases is required for glypican-3 modulation of cell survival, Wnt signaling, and gastrulation movements

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

Overgrowth syndromes and the regulation of signaling complexes by proteoglycans

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

Glypicans in growth control and cancer

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

Mapping of Simpson-Golabi-Behmel syndrome to Xq25-q27

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

Integral membrane heparan sulfate proteoglycans

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

Dipeptidyl-peptidase IV/CD26 on T cells: analysis of an alternative T-cell activation pathway

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

The structure and function of CD26 in the T-cell immune response

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

Large scale deletions in the GPC3 gene may account for a minority of cases of Simpson-Golabi-Behmel syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressor

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021

The degradation of bioactive peptides and proteins by dipeptidyl peptidase IV from human placenta

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.200600654

7 January 2021